$ACHC
Acadia Healthcare Company, Inc.

2014 Q4 Form 10-Q Financial Statement

#000119312514389873 Filed on October 30, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q3
Revenue $294.9M $294.5M $184.7M
YoY Change 55.21% 59.43% 79.12%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $200.1M $200.8M $125.2M
YoY Change 52.52% 60.38% 75.84%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $11.00M $10.30M $4.400M
YoY Change 124.49% 134.09% 120.0%
% of Gross Profit
Operating Expenses $242.5M $261.3M $162.4M
YoY Change 54.26% 60.9% 75.01%
Operating Profit $65.07M $38.48M
YoY Change 69.09%
Interest Expense -$14.70M -$12.50M $9.465M
YoY Change 53.13% -232.07% 27.34%
% of Operating Profit -19.21% 24.6%
Other Income/Expense, Net
YoY Change
Pretax Income $34.84M $33.16M $22.29M
YoY Change 74.77% 48.77% 116.15%
Income Tax $12.50M $7.703M $7.741M
% Of Pretax Income 35.88% 23.23% 34.73%
Net Earnings $22.13M $25.40M $14.36M
YoY Change 80.2% 76.84% 122.7%
Net Earnings / Revenue 7.5% 8.63% 7.78%
Basic Earnings Per Share $0.38 $0.43 $0.29
Diluted Earnings Per Share $0.37 $0.43 $0.29
COMMON SHARES
Basic Shares Outstanding 59.92M shares 59.18M shares 50.04M shares
Diluted Shares Outstanding 59.41M shares 50.34M shares

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $94.00M $42.20M $4.000M
YoY Change 1943.48% 955.0% -65.81%
Cash & Equivalents $94.04M $42.18M $4.034M
Short-Term Investments
Other Short-Term Assets $41.57M $37.63M $32.52M
YoY Change 43.5% 15.72% 112.45%
Inventory $3.249M
Prepaid Expenses $11.75M
Receivables $118.4M $130.3M $93.31M
Other Receivables $12.71M $0.00 $0.00
Total Short-Term Assets $274.1M $229.8M $142.9M
YoY Change 88.9% 60.86% 64.17%
LONG-TERM ASSETS
Property, Plant & Equipment $1.070B $1.026B $329.7M
YoY Change 189.02% 211.27% 112.47%
Goodwill $803.0M $804.6M $647.0M
YoY Change 21.38% 24.36% 93.36%
Intangibles $21.64M $21.62M $19.18M
YoY Change 5.19% 12.71% 53.05%
Long-Term Investments
YoY Change
Other Assets $25.35M $42.05M $24.18M
YoY Change -7.17% 73.91% 68.1%
Total Long-Term Assets $1.933B $1.911B $1.020B
YoY Change 79.04% 87.3% 97.42%
TOTAL ASSETS
Total Short-Term Assets $274.1M $229.8M $142.9M
Total Long-Term Assets $1.933B $1.911B $1.020B
Total Assets $2.207B $2.140B $1.163B
YoY Change 80.21% 84.05% 92.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $48.70M $43.26M $26.45M
YoY Change 35.17% 63.56% 98.52%
Accrued Expenses $30.96M $29.75M $29.24M
YoY Change 20.23% 1.75% 118.6%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $26.97M $13.32M $13.31M
YoY Change 77.46% 0.11% 10.88%
Total Short-Term Liabilities $165.9M $142.5M $101.3M
YoY Change 44.68% 40.75% 75.15%
LONG-TERM LIABILITIES
Long-Term Debt $1.053B $1.016B $572.0M
YoY Change 74.88% 77.64% 100.95%
Other Long-Term Liabilities $43.51M $30.58M $18.25M
YoY Change 124.87% 67.59% 177.55%
Total Long-Term Liabilities $1.096B $1.047B $590.2M
YoY Change 76.44% 77.33% 102.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $165.9M $142.5M $101.3M
Total Long-Term Liabilities $1.096B $1.047B $590.2M
Total Liabilities $1.326B $1.254B $696.5M
YoY Change 78.24% 80.04% 98.88%
SHAREHOLDERS EQUITY
Retained Earnings $101.4M $79.31M $6.122M
YoY Change 451.26% 1195.54% -121.45%
Common Stock $847.9M $592.0K $500.0K
YoY Change 169140.12% 18.4% 19.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $881.0M $886.6M $466.5M
YoY Change
Total Liabilities & Shareholders Equity $2.207B $2.140B $1.163B
YoY Change 80.21% 84.05% 92.62%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income $22.13M $25.40M $14.36M
YoY Change 80.2% 76.84% 122.7%
Depreciation, Depletion And Amortization $11.00M $10.30M $4.400M
YoY Change 124.49% 134.09% 120.0%
Cash From Operating Activities $46.30M $39.80M $17.00M
YoY Change 138.66% 134.12% 32.81%
INVESTING ACTIVITIES
Capital Expenditures -$43.50M -$31.30M -$21.70M
YoY Change 101.39% 44.24% -50.46%
Acquisitions
YoY Change
Other Investing Activities -$16.10M -$697.9M -$14.40M
YoY Change -44.86% 4746.53% -80.98%
Cash From Investing Activities -$59.60M -$729.1M -$36.00M
YoY Change 16.86% 1925.28% -69.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 66.80M 455.2M 15.80M
YoY Change 108.1% 2781.01% -977.78%
NET CHANGE
Cash From Operating Activities 46.30M 39.80M 17.00M
Cash From Investing Activities -59.60M -729.1M -36.00M
Cash From Financing Activities 66.80M 455.2M 15.80M
Net Change In Cash 53.50M -234.1M -3.200M
YoY Change 10600.0% 7215.62% -97.05%
FREE CASH FLOW
Cash From Operating Activities $46.30M $39.80M $17.00M
Capital Expenditures -$43.50M -$31.30M -$21.70M
Free Cash Flow $89.80M $71.10M $38.70M
YoY Change 119.02% 83.72% -31.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q4 us-gaap Long Term Debt
LongTermDebt
150000000
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8881794 shares
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
44.00
CY2014Q2 us-gaap Common Stock Discount On Shares
CommonStockDiscountOnShares
15600000
CY2014Q2 us-gaap Number Of Foreign Currency Derivatives Held
NumberOfForeignCurrencyDerivativesHeld
2 Contract
CY2014Q3 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
6302000
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4034000
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59182578 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59182578 shares
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
31.92
CY2014Q3 us-gaap Minority Interest Ownership Percentage By Parent
MinorityInterestOwnershipPercentageByParent
1.00 pure
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
118008 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
29.04
CY2014Q3 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
24 State
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
4700000 shares
CY2014Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
778295 shares
CY2014Q3 us-gaap Defined Benefit Pension Plan Current And Noncurrent Liabilities
DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities
6300000
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
50237000
CY2014Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
142540000
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
592000
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-36857000
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
43260000
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
79313000
CY2014Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
13320000
CY2014Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
64771000
CY2014Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
3467000
CY2014Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
29747000
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
886576000
CY2014Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
30579000
CY2014Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1016002000
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2140468000
CY2014Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2346000
CY2014Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
843528000
CY2014Q3 us-gaap Liabilities
Liabilities
1253892000
CY2014Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
56213000
CY2014Q3 us-gaap Long Term Debt
LongTermDebt
1029322000
CY2014Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
135600000
CY2014Q3 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
5775000
CY2014Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
21730000
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42179000
CY2014Q3 us-gaap Goodwill
Goodwill
804647000
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1026378000
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
14349000
CY2014Q3 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
62800000
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
500000
CY2014Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
20620000
CY2014Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
15933000
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
0
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive
0
CY2014Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1076615000
CY2014Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3840000
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
400000
CY2014Q3 us-gaap Assets
Assets
2140468000
CY2014Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
19782000
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
500000
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
130253000
CY2014Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
21621000
CY2014Q3 us-gaap Other Assets Current
OtherAssetsCurrent
37626000
CY2014Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
42049000
CY2014Q3 us-gaap Assets Current
AssetsCurrent
229840000
CY2014Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3347000
CY2014Q3 achc Intangible Assets Gross Carrying Amount
IntangibleAssetsGrossCarryingAmount
23967000
CY2014Q3 achc Business Combination Contingent Consideration Liability Fair Value
BusinessCombinationContingentConsiderationLiabilityFairValue
3467000
CY2014Q3 achc Intangible Assets Accumulated Amortization Carrying Amount
IntangibleAssetsAccumulatedAmortizationCarryingAmount
2346000
CY2014Q3 achc Indefinite Lived Intangible Assets Excluding Goodwill Accumulated Amortization
IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedAmortization
CY2014Q3 achc Investments In Subsidiaries
InvestmentsInSubsidiaries
0
CY2014Q3 achc Consolidated Funded Debt Maximum
ConsolidatedFundedDebtMaximum
20000000
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
59918574 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.13
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
555097 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
21.93
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
133647 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
11.15
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49399000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5632000
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50070980 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50070980 shares
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
114690000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
36026000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
798809 shares
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
29289000
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
501000
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
18402000
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
15195000
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
7971000
CY2013Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
6500000
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
25748000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
480710000
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
19347000
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
601941000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1224659000
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1931000
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
461807000
CY2013Q4 us-gaap Liabilities
Liabilities
743949000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
37721000
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
617136000
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
18345000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4569000
CY2013Q4 us-gaap Goodwill
Goodwill
661549000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
370109000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
10700000
CY2013Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
19152000
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
399398000
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3472000
CY2013Q4 us-gaap Assets
Assets
1224659000
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
15703000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
95885000
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20568000
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
28969000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
27307000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
145126000
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3347000
CY2013Q4 achc Intangible Assets Gross Carrying Amount
IntangibleAssetsGrossCarryingAmount
22499000
CY2013Q4 achc Business Combination Contingent Consideration Liability Fair Value
BusinessCombinationContingentConsiderationLiabilityFairValue
6500000
CY2013Q4 achc Intangible Assets Accumulated Amortization Carrying Amount
IntangibleAssetsAccumulatedAmortizationCarryingAmount
1931000
CY2013Q4 achc Indefinite Lived Intangible Assets Excluding Goodwill Accumulated Amortization
IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedAmortization
CY2013Q4 achc Investments In Subsidiaries
InvestmentsInSubsidiaries
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
15.31
dei Document Type
DocumentType
10-Q
dei Entity Registrant Name
EntityRegistrantName
Acadia Healthcare Company, Inc.
dei Trading Symbol
TradingSymbol
ACHC
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
252000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.61
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.62
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
539230000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
8000000
us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
523409000
us-gaap Repayments Of Debt
RepaymentsOfDebt
52500000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
700000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49987000 shares
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
5625000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-27672000
CY2014Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
800000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.60
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
226000 shares
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.374 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
46228000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
46769000
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.61
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50213000 shares
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1676000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
49310000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
135605000
us-gaap Operating Income Loss
OperatingIncomeLoss
106137000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-572000
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
4676000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1088000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4307000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
16417000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
50678000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-16000
us-gaap Net Income Loss
NetIncomeLoss
30299000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18378000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
5657000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
30871000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-9350000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
30299000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
764605000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
10545000
us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
1300000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2114000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
3538000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M
us-gaap Operating Expenses
OperatingExpenses
474099000
us-gaap Professional Fees
ProfessionalFees
27294000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1686000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1265000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
298904000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
600000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-45365000
us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
9350000
us-gaap Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
28017000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18439000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
12248000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
100454000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-192047000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3813000
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-541000
us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
15821000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
7377000
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
163706000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2596000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
27500000
us-gaap Severance Costs1
SeveranceCosts1
1169000
us-gaap Share Based Compensation
ShareBasedCompensation
3744000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
59424000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
150000000
achc Payments To Proceeds From Contributions From Affiliates
PaymentsToProceedsFromContributionsFromAffiliates
0
achc Common Stock Withheld For Minimum Statutory Taxes Net
CommonStockWithheldForMinimumStatutoryTaxesNet
1120000
achc Deposits Related To Acquisition
DepositsRelatedToAcquisition
11684000
achc Payment Of Premium On Redemption Of Debt
PaymentOfPremiumOnRedemptionOfDebt
6759000
achc Capitalized Cost Incurred
CapitalizedCostIncurred
300000
achc Legal Accounting And Other Fees
LegalAccountingAndOtherFees
2644000
achc Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Income Taxes
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeIncomeTaxes
19707000
us-gaap Common Stock Voting Rights
CommonStockVotingRights
One vote for each share
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.13
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.333 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
69046000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
69073000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
17.80
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
55889 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y7M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y5M1D
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.13
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
218263 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.017 pure
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
33.65
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y4D
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53922000 shares
us-gaap Debt Instrument Covenant Description
DebtInstrumentCovenantDescription
The Company may now invest, in any given fiscal year, up to five percent (5%) of its total assets in both joint ventures and foreign subsidiaries, respectively; provided that the aggregate amount of investments in both joint ventures and foreign subsidiaries, respectively, may not exceed ten percent (10%) of its total assets over the life of the Amended and Restated Senior Credit Facility; provided further that the aggregate amount of investments made in both joint ventures and foreign subsidiaries collectively pursuant to the foregoing may not exceed fifteen percent (15%) of its total assets.
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.14
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.14
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
49.68
dei Entity Central Index Key
EntityCentralIndexKey
0001520697
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.36 pure
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
700000 shares
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
860151000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
91314000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
120000000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-33505000
us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
729784000
us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
15262000
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
15300000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-36857000
us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
709700000
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
3779000
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
104000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2086000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
182888 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53670000 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
374431000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
5625000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-36857000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
570000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
722797000
us-gaap Operating Income Loss
OperatingIncomeLoss
149062000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-20000
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
22247000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
733000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
10909000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
78003000
us-gaap Goodwill Other Changes
GoodwillOtherChanges
-414000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
70680000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-163000
us-gaap Net Income Loss
NetIncomeLoss
60911000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
25395000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6975000
us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
-15262000
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
1467000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-1322000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
60931000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
24054000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4645000
us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
3800000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1440000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
8972000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
3805000
us-gaap Operating Expenses
OperatingExpenses
618386000
us-gaap Professional Fees
ProfessionalFees
36151000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2229000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
500000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
3779000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
408680000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
37610000
us-gaap Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
34722000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30383000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
21696000
us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
-6199000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
148883000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
771199000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
374431000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-801195000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
10834000
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-27000
us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
20084000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
8872000
us-gaap Unrecognized Tax Benefits Income Tax Penalties Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense
33600000
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
802767000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1078000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
150000000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
230500000
us-gaap Severance Costs1
SeveranceCosts1
763000
us-gaap Share Based Compensation
ShareBasedCompensation
6975000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
4994000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
79188000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
307500000
achc Payments To Proceeds From Contributions From Affiliates
PaymentsToProceedsFromContributionsFromAffiliates
0
achc Common Stock Withheld For Minimum Statutory Taxes Net
CommonStockWithheldForMinimumStatutoryTaxesNet
3477000
achc Share Based Compensation Shares Authorized Under Stock Option Plans Options Available For Future Grants
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansOptionsAvailableForFutureGrants
2664749 shares
achc Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P9Y3M4D
achc Deposits Related To Acquisition
DepositsRelatedToAcquisition
500000
achc Share Based Compensation Arrangement By Share Based Payment Award
ShareBasedCompensationArrangementByShareBasedPaymentAward
0.25 pure
achc Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue
97000
achc Common Stock Withheld For Minimum Statutory Taxes
CommonStockWithheldForMinimumStatutoryTaxes
4047000
achc Share Based Compensation Arrangement By Share Based Payment Stock Options Granted Term
ShareBasedCompensationArrangementByShareBasedPaymentStockOptionsGrantedTerm
P10Y
achc Capitalized Cost Incurred
CapitalizedCostIncurred
400000
achc Payments For Contingent Consideration Liability
PaymentsForContingentConsiderationLiability
5000000
achc Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodAggregateIntrinsicValue
achc Legal Accounting And Other Fees
LegalAccountingAndOtherFees
10071000
achc Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Income Taxes
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeIncomeTaxes
64607000
CY2012Q2 us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
-200000
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.36
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.62
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
411800 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.010 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
23.50
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y2M12D
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y9M22D
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
41426 shares
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
30.55
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.40 pure
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
126662 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2803000
CY2013 achc Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P9Y3M18D
CY2013 achc Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue
2059000
CY2013 achc Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodAggregateIntrinsicValue
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M11D
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2013Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
303000 shares
CY2013Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.347 pure
CY2013Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.29
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50343000 shares
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2013Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.29
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
400000 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50040000 shares
CY2013Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-9465000
CY2013Q3 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
190574000
CY2013Q3 us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
184702000
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22287000
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
38481000
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-182000
CY2013Q3 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
14364000
CY2013Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0
CY2013Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
14546000
CY2013Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
14364000
CY2013Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
261409000
CY2013Q3 us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
100000
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
162415000
CY2013Q3 us-gaap Professional Fees
ProfessionalFees
8956000
CY2013Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
103789000
CY2013Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000
CY2013Q3 us-gaap Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
9806000
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7741000
CY2013Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4414000
CY2013Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
984000
CY2013Q3 us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
5872000
CY2013Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2656000
CY2013Q3 us-gaap Severance Costs1
SeveranceCosts1
143000
CY2013Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1331000
CY2013Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
22345000
CY2013Q3 achc Legal Accounting And Other Fees
LegalAccountingAndOtherFees
841000
CY2013Q3 achc Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Income Taxes
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeIncomeTaxes
12044000
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2014Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
234000 shares
CY2014Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.232 pure
CY2014Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.43
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59409000 shares
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2014Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.43
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59175000 shares
CY2014Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-36857000
CY2014Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-14068000
CY2014Q3 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
303001000
CY2014Q3 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
1527000
CY2014Q3 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
1500000
CY2014Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-36857000
CY2014Q3 us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
294479000
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
33156000
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
65066000
CY2014Q3 us-gaap Defined Benefit Plan Foreign Currency Exchange Rate Changes Benefit Obligation
DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
-327000
CY2014Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-51000
CY2014Q3 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
25402000
CY2014Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0
CY2014Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
25453000
CY2014Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-11455000
CY2014Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
296479000
CY2014Q3 us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
300000
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
261323000
CY2014Q3 us-gaap Professional Fees
ProfessionalFees
14878000
CY2014Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
168632000
CY2014Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000
CY2014Q3 us-gaap Defined Benefit Plan Benefits Paid
DefinedBenefitPlanBenefitsPaid
897000
CY2014Q3 us-gaap Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
14062000
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7703000
CY2014Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10325000
CY2014Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
6239000
CY2014Q3 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
1097000
CY2014Q3 us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
8522000
CY2014Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
3214000
CY2014Q3 us-gaap Severance Costs1
SeveranceCosts1
304000
CY2014Q3 us-gaap Share Based Compensation
ShareBasedCompensation
2805000
CY2014Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
31432000
CY2014Q3 achc Legal Accounting And Other Fees
LegalAccountingAndOtherFees
5935000
CY2014Q3 achc Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Income Taxes
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeIncomeTaxes
33406000

Files In Submission

Name View Source Status
0001193125-14-389873-index-headers.html Edgar Link pending
0001193125-14-389873-index.html Edgar Link pending
0001193125-14-389873.txt Edgar Link pending
0001193125-14-389873-xbrl.zip Edgar Link pending
achc-20140930.xml Edgar Link completed
achc-20140930.xsd Edgar Link pending
achc-20140930_cal.xml Edgar Link unprocessable
achc-20140930_def.xml Edgar Link unprocessable
achc-20140930_lab.xml Edgar Link unprocessable
achc-20140930_pre.xml Edgar Link unprocessable
d797506d10q.htm Edgar Link pending
d797506dex311.htm Edgar Link pending
d797506dex312.htm Edgar Link pending
d797506dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending